News
WY Biotech is now obligated to pay a $7 million upfront license fee to HCW Biologics by Sept. 30, according to a filing with the Securities and Exchange Commission. HCW Biologics previously said it ...
The US pharmaceutical industry has undergone notable shifts in recent years, influenced by factors such as the COVID-19 ...
12h
Investor's Business Daily on MSNThe FDA Will Reportedly Ask Sarepta To Stop Selling Elevidys. Shares Plummet.Sarepta stock crashed Friday on reports the FDA will ask the biotech company to stop shipments of its approved gene therapy, ...
19h
Barchart on MSNThis ‘Strong Buy’ Stock Could Be the Next Big Biotech BreakoutClinical-stage biotech stocks carry significant risks, but also offer explosive upside potential. These companies are built ...
The pharmaceutical sector continues to stand out as a resilient and highly profitable corner of the market, even amid global ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results